A Novel Approach for Quantifying GPCR Dimerization Equilibrium Using Bioluminescence Resonance Energy Transfer
暂无分享,去创建一个
R. Abagyan | R. Stevens | T. Handel | Bryan S. Stephens | I. Kufareva | G. Fenalti | B. Wu | C. T. Gilliland | Damon | Hamel
[1] L. Pardo,et al. Crystal structure of the μ-opioid receptor bound to a morphinan antagonist , 2012, Nature.
[2] Bryan L. Roth,et al. Structure of the human kappa opioid receptor in complex with JDTic , 2012, Nature.
[3] M. Nieman,et al. Mapping Human Protease-activated Receptor 4 (PAR4) Homodimer Interface to Transmembrane Helix 4* , 2012, The Journal of Biological Chemistry.
[4] L. Drinovec,et al. Quantitative Assessment of Seven Transmembrane Receptors (7TMRs) Oligomerization by Bioluminescence Resonance Energy Transfer (BRET) Technology , 2012 .
[5] J. Selent,et al. Oligomerization of G protein-coupled receptors: biochemical and biophysical methods. , 2011, Current medicinal chemistry.
[6] R. Koenen,et al. Heterophilic chemokine receptor interactions in chemokine signaling and biology. , 2011, Experimental cell research.
[7] T. Kenakin. Functional Selectivity and Biased Receptor Signaling , 2011, Journal of Pharmacology and Experimental Therapeutics.
[8] K. Pfleger,et al. Study of GPCR-protein interactions by BRET. , 2011, Methods in molecular biology.
[9] L. Prézeau,et al. Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to G protein-coupled receptor oligomerization. , 2011, Methods in molecular biology.
[10] S. Marullo,et al. Using quantitative BRET to assess G protein-coupled receptor homo- and heterodimerization. , 2011, Methods in molecular biology.
[11] R. Abagyan,et al. Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.
[12] P. Sexton,et al. Importance of lipid-exposed residues in transmembrane segment four for family B calcitonin receptor homo-dimerization , 2010, Regulatory Peptides.
[13] J. Javitch,et al. Time-resolved FRET between GPCR ligands reveals oligomers in native tissues. , 2010, Nature chemical biology.
[14] F. Ciruela,et al. Lighting up multiprotein complexes: lessons from GPCR oligomerization. , 2010, Trends in biotechnology.
[15] George Khelashvili,et al. GPCR-OKB: the G Protein Coupled Receptor Oligomer Knowledge Base , 2010, Bioinform..
[16] L. Miller,et al. Dimeric Arrangement of the Parathyroid Hormone Receptor and a Structural Mechanism for Ligand-induced Dissociation* , 2010, The Journal of Biological Chemistry.
[17] R. Franco,et al. Oligomerization of G-protein-coupled receptors: a reality. , 2010, Current opinion in pharmacology.
[18] K. Pfleger,et al. Recent advances in bioluminescence resonance energy transfer technologies to study GPCR heteromerization. , 2010, Current opinion in pharmacology.
[19] Gregory I. Mashanov,et al. Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules , 2010, Proceedings of the National Academy of Sciences.
[20] M. Parmentier,et al. Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the Protean Effects of “Selective” Antagonists* , 2009, The Journal of Biological Chemistry.
[21] Ruben Abagyan,et al. Functional Importance of a Structurally Distinct Homodimeric Complex of the Family B G Protein-Coupled Secretin Receptor , 2009, Molecular Pharmacology.
[22] M. Robitaille,et al. Novel tools for use in bioluminescence resonance energy transfer (BRET) assays. , 2009, Methods in molecular biology.
[23] T. Handel,et al. Modulation of chemokine receptor activity through dimerization and crosstalk , 2009, Cellular and Molecular Life Sciences.
[24] L. Miller,et al. Dimerization in the absence of higher-order oligomerization of the G protein-coupled secretin receptor. , 2008, Biochimica et biophysica acta.
[25] Tullio Pozzan,et al. CXCR4–CCR5: A couple modulating T cell functions , 2008, Proceedings of the National Academy of Sciences.
[26] F. Baleux,et al. CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome. , 2008, Blood.
[27] V. Gurevich,et al. GPCR monomers and oligomers: it takes all kinds , 2008, Trends in Neurosciences.
[28] L. Miller,et al. Transmembrane Segment IV Contributes a Functionally Important Interface for Oligomerization of the Class II G Protein-coupled Secretin Receptor* , 2007, Journal of Biological Chemistry.
[29] Marc Parmentier,et al. Allosteric Transinhibition by Specific Antagonists in CCR2/CXCR4 Heterodimers* , 2007, Journal of Biological Chemistry.
[30] S. Marullo,et al. Resonance energy transfer approaches in molecular pharmacology and beyond. , 2007, Trends in pharmacological sciences.
[31] A. Salahpour,et al. Experimental challenge to a 'rigorous' BRET analysis of GPCR oligomerization , 2007, Nature Methods.
[32] Michel Bouvier,et al. Requirements and ontology for a G protein-coupled receptor oligomerization knowledge base , 2007, BMC Bioinformatics.
[33] D. Oprian,et al. Transducin Activation by Nanoscale Lipid Bilayers Containing One and Two Rhodopsins* , 2007, Journal of Biological Chemistry.
[34] Richard N. Zare,et al. A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein , 2007, Proceedings of the National Academy of Sciences.
[35] Andrea Iaboni,et al. A rigorous experimental framework for detecting protein oligomerization using bioluminescence resonance energy transfer , 2006, Nature Methods.
[36] C. Combs,et al. Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions , 2006, Molecular Cancer Therapeutics.
[37] K. Eidne,et al. Illuminating insights into protein-protein interactions using bioluminescence resonance energy transfer (BRET) , 2006, Nature Methods.
[38] T. Issad,et al. Bioluminescence resonance energy transfer to monitor protein-protein interactions. , 2006, Methods in molecular biology.
[39] Marc Parmentier,et al. Dimerization of chemokine receptors and its functional consequences. , 2005, Cytokine & growth factor reviews.
[40] Michel Bouvier,et al. Methods to monitor the quaternary structure of G protein‐coupled receptors , 2005, The FEBS journal.
[41] Mario Mellado,et al. Response to "On the dimerization of CCR5" , 2005, Nature Immunology.
[42] S. Marullo,et al. On the dimerization of CCR5 , 2005, Nature Immunology.
[43] Michel Bouvier,et al. Bioluminescence Resonance Energy Transfer Reveals Ligand-induced Conformational Changes in CXCR4 Homo- and Heterodimers* , 2005, Journal of Biological Chemistry.
[44] Alain Dupuy,et al. WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12. , 2005, Blood.
[45] Michel Bouvier,et al. Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. , 2005, Trends in pharmacological sciences.
[46] M. Parmentier,et al. Evidence for Negative Binding Cooperativity within CCR5-CCR2b Heterodimers , 2005, Molecular Pharmacology.
[47] Graeme Milligan,et al. G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology , 2004, Molecular Pharmacology.
[48] Alfonso Valencia,et al. Identification of amino acid residues crucial for chemokine receptor dimerization , 2004, Nature Immunology.
[49] M. Bouvier,et al. Roles of G‐protein‐coupled receptor dimerization , 2004, EMBO reports.
[50] R. Gorlin,et al. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease , 2003, Nature Genetics.
[51] Michel Bouvier,et al. Constitutive Agonist-independent CCR5 Oligomerization and Antibody-mediated Clustering Occurring at Physiological Levels of Receptors* 210 , 2002, The Journal of Biological Chemistry.
[52] T. Issad,et al. The use of resonance energy transfer in high-throughput screening: BRET versus FRET. , 2002, Trends in pharmacological sciences.
[53] Michel Bouvier,et al. Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. , 2002, Annual review of pharmacology and toxicology.
[54] R. Tsien,et al. Reducing the Environmental Sensitivity of Yellow Fluorescent Protein , 2001, The Journal of Biological Chemistry.
[55] Mario Mellado,et al. Chemokine receptor homo‐ or heterodimerization activates distinct signaling pathways , 2001, The EMBO journal.
[56] Richard N. Day,et al. Fluorescent protein spectra. , 2001, Journal of cell science.
[57] G. Milligan,et al. Ligand regulation of green fluorescent protein-tagged forms of the human beta(1)- and beta(2)-adrenoceptors; comparisons with the unmodified receptors. , 2000, British journal of pharmacology.
[58] Charles R. Gerfen,et al. Current Protocols In Neuroscience , 1999 .
[59] R. Doms,et al. An Intricate Web: Chemokine Receptors, HIV‐1 and Hematopoiesis , 1998, Stem cells.
[60] Kuan-Teh Jeang,et al. Mechanism of Transdominant Inhibition of CCR5-mediated HIV-1 Infection by ccr5Δ32* , 1997, The Journal of Biological Chemistry.
[61] Richard A Koup,et al. Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.
[62] L. Stryer,et al. The dimeric nature of the gramicidin A transmembrane channel: conductance and fluorescence energy transfer studies of hybrid channels. , 1977, Journal of molecular biology.